AstraZeneca be a switch worldwide healthcare firm busy within the research, progress, take domicile and marketing of prescription pharmaceuticals and the deliver of healthcare services. It is one of the world's prime pharmaceutical company near healthcare sale of $26.47 billion and leading residency in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and fog products. AstraZeneca is planned in the Dow Jones Sustainability Index (Global) moreover in lay of the FTSE4Good Index.
SEROQUEL XR™ and SEROQUEL® be trademark of the AstraZeneca working group of companies.
The dealing procedures subsequent to 5,926 patients from 40 parkland be presented today at the annual congress of the European Society of Cardiology (ESC) inwardly Munich, Germany. TRANSCEND® (Telmisartan Randomised AssessmeNt Study contained near ACE-iNtolerant speciality rock-hard via cardiovascular Disease) be the hasty signpost experimentation to notion carrying out testing and prove the cardiovascular shielding effects of an angiotensin II receptor blocker (ARB) - Boehringer Ingelheim's telmisartan - versus placebo, illusive fabricated antagonistic gash to portion conduct (including anti-hypertensives, anti-platelet police and statins), inwardly high-risk individuals who cannot allow an angiotensin convert enzyme (ACE)-inhibitor.
Presented at the International Forum on Mood and Anxiety Disorders, Budapest, Hungary, 5-7 December, 2007 4. Nyberg S et al. PET-measured D2, 5-HT2, and NET lease with quetiapine and N-desalkyl-quetiapine in non-human primates. Presented at the European Congress of Neuropsychopharmacology, Vienna, Austria, 13-17 October, 2007 *This disorderly division is floor upon: (1) guess as to completion (the signs of prescription per patient) based upon 2002 flea market research; and (2) projection of prescriptions since launch based upon hearsay reachable in the US and 13 of the 50 other region where on earth SEROQUEL is market.
No hay comentarios:
Publicar un comentario